Clinical Trial Update: Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating abatacept subcutaneous plus methotrexate for inducing remission in adults with very early rheumatoid arthritis, reporting efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Orencia (abatacept) (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-10-17